Role of insulin and insulin resistance in androgen excess disorders
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Insulin has complex effects on cell growth, metabolism and differentiation, and these effects are mediated by a cell-surface bound receptor and eventually a cascade of intracellular signaling events. Among the several metabolic and growth-promoting effects of insulin, insulin resistance is defined as an attenuated effect of insulin on glucose metabolism, primarily the limited export of blood glucose into skeletal muscle and adipose tissue. On the other hand, not all the signaling pathways and insulin-responsive tissues are equally affected, and some effects other than the metabolic actions of insulin are overexpressed. Ovaries and the adrenal glands are two examples of tissues remaining sensitive to insulin actions where insulin may contribute to increased androgen secretion. Polycystic ovary syndrome (PCOS) is the most common form of androgen excess disorder (AED), and its pathogenesis is closely associated with insulin resistance. Patients with idiopathic hirsutism also exhibit insulin resistance, albeit lower than patients with PCOS. Although it is not as evident as in PCOS, patients with congenital adrenal hyperplasia may have insulin resistance, which may be further exacerbated with glucocorticoid overtreatment and obesity. Among patients with severe insulin resistance syndromes, irrespective of the type of disease, hyperinsulinemia promotes ovarian androgen synthesis independently of gonadotropins. It is highly debated in whom and how insulin resistance should be diagnosed and treated among patients with AEDs, including PCOS. It is not suitable to administer an insulin sensitizer relying on only some mathematical models used for estimating insulin resistance. Instead, the treatment decision should be based on the constellation of the signs, symptoms and presence of obesity; acanthosis nigricans; and some laboratory abnormalities such as impaired glucose tolerance and impaired fasting glucose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.004 · Cited by 1,325
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739
Ueki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339
Baillargeon, J.-P., Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., & Nestler, J. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.127 · Cited by 300
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Tosi, F., Bonora, E., & Moghetti, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex308 · Cited by 163
Hirsch, A., Hahn, D., Kempná, P., Hofer, G., Nuoffer, J.-M., Mullis, P. E., & Flück, C. E. (2012) · Endocrinology · doi:10.1210/en.2012-1145 · Cited by 109
Thecal Cell Sensitivity to Luteinizing Hormone and Insulin in Polycystic Ovarian Syndrome
Cadagan, D., Khan, R., & Amer, S. (2016) · Reproductive Biology · doi:10.1016/j.repbio.2015.12.006 · Cited by 92
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Research works printed but not linked: 55
- 10.1038/embor.2010.160 · DOI · Paper page
- 10.1007/s00125-002-0945-z · DOI
- 10.1101/cshperspect.a009191 · DOI · Paper page
- 10.1073/pnas.0901933106 · DOI · Paper page
- 10.1002/1873-3468.12740 · DOI · Paper page
- 10.2337/db06-0148 · DOI · Paper page
- 10.1073/pnas.0711713105 · DOI · Paper page
- 10.1016/j.cmet.2013.04.010 · DOI · Paper page
- 10.2337/dc12-0825 · DOI · Paper page
- 10.2337/db14-0694 · DOI · Paper page
- 10.1159/000341822 · DOI
- 10.1159/000494907 · DOI
- 10.1002/jemt.20304 · DOI
- 10.1016/j.rbmo.2014.02.003 · DOI
- 10.1016/j.fertnstert.2011.11.036 · DOI · Paper page
- 10.5114/aoms.2019.82672 · DOI
- 10.1681/ASN.2006121410 · DOI
- 10.1210/jcem.84.9.6010 · DOI · Paper page
- 10.1016/j.jsbmb.2018.01.008 · DOI
- 10.2174/1381612822666160810111528 · DOI
- 10.1007/s43032-020-00194-7 · DOI
- 10.1016/j.beem.2006.03.005 · DOI · Paper page
- 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
- 10.1111/j.1365-2265.2006.02587.x · DOI · Paper page
- 10.1046/j.1365-2265.1999.00786.x · DOI · Paper page
- 10.1210/en.2003-0329 · DOI · Paper page
- 10.1093/humrep/15.1.21 · DOI · Paper page
- 10.1093/oxfordjournals.humrep.a137577 · DOI · Paper page
- 10.1530/EJE-10-0782 · DOI · Paper page
- 10.1210/clinem/dgaa095 · DOI
- 10.1016/j.jpeds.2003.08.015 · DOI
- 10.1210/jcem.87.6.8568 · doi:10.1210/jcem.87.6.8568 · Paper page
- 10.1210/jcem.81.3.8772557 · DOI · Paper page
- 10.1210/jc.2003-031626 · DOI
- 10.1055/s-2004-821307 · DOI · Paper page
- 10.1155/2013/593197 · DOI
- 10.1159/000096434 · DOI
- 10.3109/09513590.2014.994598 · DOI
- 10.1111/ajd.12276 · DOI
- 10.1530/EJE-15-0460 · DOI
- 10.1016/j.jsbmb.2016.06.015 · DOI
- 10.3109/09513590903215466 · DOI
- 10.1159/000086363 · DOI · Paper page
- 10.1055/a-1116-2173 · DOI
- 10.1530/EJE-09-0523 · DOI
- 10.1007/s11892-017-0829-8 · DOI
- 10.1016/j.jsbmb.2020.105684 · DOI
- 10.1056/NEJM197604012941401 · DOI · Paper page
- 10.1111/j.1365-2265.2005.02302.x · DOI
- 10.1100/tsw.2006.23 · DOI
- 10.1530/EDM-19-0150 · DOI
- 10.1111/dme.12189 · DOI
- 10.1038/oby.2008.336 · DOI · Paper page
- 10.1007/978-981-15-1792-1_8 · DOI
- 10.1007/s00404-017-4422-9 · DOI
Cited by
The Role of Lifestyle Interventions in PCOS Management: A Systematic Review
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115
“Further, stable insulin levels help to reduce excess androgen (testosterone) production and help to control symptoms like acne, hir-sutism, and irregular menstrual cycles [87].”
Muhammed Saeed, A. A., Noreen, S., Awlqadr, F. H., Farooq, M. I., Qadeer, M., Rai, N., Farag, H. A., & Saeed, M. N. (2025) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-025-00899-y · Cited by 29
“Consequently, this can impede the body’s capacity to react to insulin efficiently [56].”
Dutta, S., Sengupta, P., Rao, S., Elgarawany, G. E., Samrot, A. V., Rosas, I. M., & Roychoudhury, S. (2025) · Pharmaceuticals · doi:10.3390/ph18101575 · Cited by 20
“This selective IR results in compensatory hyperinsulinemia, which augments ovarian androgen synthesis by stimulating cytochrome P450c17 α and synergizing with luteinizing hormone (LH) [14].”
Metadata
- Authors
- Unluhizarci, K., Karaca, Z., & Kelestimur, F.
- Venue
- World Journal of Diabetes
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2021-05-15
- Volume
- 12
- Issue
- 5
- Pages
- 616-629
- ISSN
- 1948-9358 (ISSN-L)
- OpenAlex
- W3157385145
- Cited by
- 184
- References
- 17
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.